BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12380485)

  • 1. Diffusion magnetic resonance imaging in intermediate form of maple syrup urine disease.
    Sener RN
    J Neuroimaging; 2002 Oct; 12(4):368-70. PubMed ID: 12380485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
    Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
    Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema.
    Righini A; Ramenghi LA; Parini R; Triulzi F; Mosca F
    J Neuroimaging; 2003 Apr; 13(2):162-5. PubMed ID: 12722501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
    Schönberger S; Schweiger B; Schwahn B; Schwarz M; Wendel U
    Mol Genet Metab; 2004 May; 82(1):69-75. PubMed ID: 15110325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings.
    Parmar H; Sitoh YY; Ho L
    J Comput Assist Tomogr; 2004; 28(1):93-7. PubMed ID: 14716239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
    Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
    J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural white matter changes in adolescents and young adults with maple syrup urine disease.
    Klee D; Thimm E; Wittsack HJ; Schubert D; Primke R; Pentang G; Schaper J; Mödder U; Antoch A; Wendel U; Cohnen M
    J Inherit Metab Dis; 2013 Nov; 36(6):945-53. PubMed ID: 23355088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral edema and intracranial hypertension in an adult with maple syrup urine disease.
    Sutter R; Killer HE; Bilz S; Baumgartner M; Ott HW; Steck AJ; Renaud S
    Eur J Neurol; 2009 Mar; 16(3):e45-6. PubMed ID: 19364339
    [No Abstract]   [Full Text] [Related]  

  • 9. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy.
    Sakai M; Inoue Y; Oba H; Ishiguro A; Sekiguchi K; Tsukune Y; Mitomo M; Nakamura H
    J Comput Assist Tomogr; 2005; 29(4):524-7. PubMed ID: 16012312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.
    Ha JS; Kim TK; Eun BL; Lee HS; Lee KY; Seol HY; Cha SH
    Pediatr Radiol; 2004 Feb; 34(2):163-6. PubMed ID: 14504844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.
    Cheng A; Han L; Feng Y; Li H; Yao R; Wang D; Jin B
    Diagn Interv Radiol; 2017; 23(5):398-402. PubMed ID: 28830848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI of maple syrup urine disease encephalopathy.
    Cavalleri F; Berardi A; Burlina AB; Ferrari F; Mavilla L
    Neuroradiology; 2002 Jun; 44(6):499-502. PubMed ID: 12070724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion magnetic resonance imaging patterns in metabolic and toxic brain disorders.
    Sener RN
    Acta Radiol; 2004 Aug; 45(5):561-70. PubMed ID: 15515520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A mild variant case of maple syrup urine disease].
    Ishikawa A; Okayasu T; Miyasaka K; Fukushima N; Takase A; Wagatsuma Y
    No To Hattatsu; 1991 Jan; 23(1):71-4. PubMed ID: 1994996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.
    Kilicarslan R; Alkan A; Demirkol D; Toprak H; Sharifov R
    Jpn J Radiol; 2012 Jul; 30(6):522-5. PubMed ID: 22476847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease.
    Xia W; Yang W
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):805-8. PubMed ID: 25879313
    [No Abstract]   [Full Text] [Related]  

  • 17. Unusual imaging findings in brain and spinal cord in two siblings with maple syrup urine disease.
    Bhat M; Prasad C; Bindu PS; Aziz Z; Christopher R; Saini J
    J Neuroimaging; 2013 Oct; 23(4):540-2. PubMed ID: 23279201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the diffusion-weighted MRI in the diagnosis and follow-up of encephalopathy caused by maple syrup urine disease in a full-term newborn.
    Ferraz-Filho JR; Floriano VH; Quirici MB; Albuquerque RP; Souza AS
    Arq Neuropsiquiatr; 2009 Sep; 67(3A):719-23. PubMed ID: 19722062
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diffusion-weighted image in the study of brain tumors and peritumoral edema].
    Pronin IN; Kornienko VN; Fadeeva LM; Rodionov PV; Golanov AV
    Zh Vopr Neirokhir Im N N Burdenko; 2000; (3):14-6; discussion 17. PubMed ID: 11221335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal maple syrup urine disease case report and literature review.
    Liu Q; Li F; Zhou J; Liu X; Peng J; Gong L
    Medicine (Baltimore); 2022 Dec; 101(50):e32174. PubMed ID: 36550798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.